Trial intelligence / Profile preview

VAIN: Xylometazoline in flexible bronchoscopy

NCT03424889Completed

Sponsor
AIIMS New Delhi
Start
Jun 2018
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing Xylometazoline with Saline placebo (2 arms). Primary endpoint: Operator rated difficulty in nasal bronchoscope negotiation. Started Jun 2018; status: completed.

02

Drugs

xylometazoline

Beyond the preview

Go deeper on NCT03424889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03424889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call